Sirona Biochem Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRBCF research report →
About the company
Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes.
- CEO
- Howard J. Verrico
- IPO
- 2013
- Employees
- 10
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $1.63M
- P/E
- -0.72
- P/S
- 66.76
- P/B
- -0.73
- EV/EBITDA
- -1.69
- Div Yield
- 0.00%
- Gross Margin
- -82.71%
- Op Margin
- -6917.60%
- Net Margin
- -7312.43%
- ROE
- 221.45%
- ROIC
- 1259.21%
- Revenue
- $34.78K · -94.82%
- Net Income
- $-2,543,190 · 28.52%
- EPS
- $-0.01 · 31.76%
- Op Income
- $-2,405,872
- FCF YoY
- 19.29%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.07
- Avg Volume
- 23.17K
Get TickerSpark's AI analysis on SRBCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SRBCF coverage
Recent articles, reports, and earnings notes.
No research on SRBCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SRBCF report →Similar companies
Peers in the same neighborhood.